Delayed but complete response following oral temozolomide treatment in melanoma leptomeningeal carcinomatosis

Case Reports in Oncology

Volumn 4, Issue 1, 2011, Pages 211-215

  Hottinger, Andreas F ^a   Favet, Laurence ^a   Pache, Jean Claude ^b   Martin, Jean Baptiste ^a   Dietrich, Pierre Yves ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Rive Droite Imaging Center   (Switzerland)

Author keywords

Delayed response; Leptomeningeal carcinomatosis; Melanoma; Temozolomide

Indexed keywords

ALPHA INTERFERON; CISPLATIN; CYTARABINE; DACARBAZINE; MELAN A; TEMOZOLOMIDE; VINBLASTINE;

ADULT; ARTICLE; CARCINOMATOUS MENINGITIS; CASE REPORT; COMORBIDITY; DRUG TOLERABILITY; HAND PARESTHESIA; HEADACHE; HUMAN; IRRADIATION; KARNOFSKY PERFORMANCE STATUS; LOW BACK PAIN; LUMBAR PUNCTURE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MELANOMA LEPTOMENINGEAL CARCINOMATOSIS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY OF LIFE; SOMNOLENCE; TREATMENT RESPONSE; URINE INCONTINENCE;

EID: 79957588581     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000327699     Document Type: Article

References (7)

1. Sampson JH, Carter JH Jr, Friedman AH, Seigler HF: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998;88:11-20. (Pubitemid 28018958)
2. Raizer JJ, Hwu WJ, Panageas KS, Wilton A, Baldwin DE, Bailey E, von Althann C, Lamb LA, Alvarado G, Bilsky MH, Gutin PH: Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro Oncol 2008;10:199-207.
3. Posner J: Leptomeningeal metastases; in Reinhardt RW (ed): Neurologic complications of cancer. Philadelphia, FA Davis Company, 1995, pp 143-171.
4. Lui P, Cashin R, Machado M, Hemels M, Corey-Lisle PK, Einarson TR: Treatments for metastatic melanoma: synthesis of evidence from randomized trials. Cancer Treat Rev 2007;33:665-680. (Pubitemid 350082665)
5. Middleton MR, Grob JJ, Aaronson N, Fierlbeck G, Tilgen W, Seiter S, Gore M, Aamdal S, Cebon J, Coates A, Dreno B, Henz M, Schadendorf D, Kapp A, Weiss J, Fraass U, Statkevich P, Muller M, Thatcher N: Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000;18:158-166. (Pubitemid 30036349)
6. Quirt I, Verma S, Petrella T, Bak K, Charette M: Temozolomide for the treatment of metastatic melanoma: a systematic review. Oncologist 2007;12:1114-1123. (Pubitemid 350007023)
7. Salmaggi A, Silvani A, Eoli M, Lamperti E, Boiardi A: Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report. Neurol Sci 2002;23:257-258. (Pubitemid 36024573)